The evaluation of low-density lipoprotein cholesterol goals achieved in patients with established cardiovascular disease and/or hyperlipidaemia receiving lipid lowering therapy
Background:Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. A major risk factor for CVD is hypercholesterolaemia. As a result the South African scientific community has updated its clinical guidelines for CVD management by adoption of the current European ca...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | en |
| Published: |
2009
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10539/6954 |